Trial intelligence / Profile preview

Efficacy of BG2109 vs Cetrorelix in ART/COH

NCT05738382Phase 2Unknown

Sponsor
Genuine Biotech
Start
Aug 2023
Primary completion
Jun 2024
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of linzagolix in female infertility, sponsored by Genuine Biotech. Status: unknown.

02

Drugs

linzagolix
03

Conditions

female infertility

Beyond the preview

Go deeper on NCT05738382.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05738382.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call